Interaction between Group 3 Innate Lymphoid Cells, Microbiota, and Intestinal Diseases: Mechanisms and Therapeutic Potential
Journal of Innate Immunity · 18.06.2025 · 17 (1) · 341-353
DOI: 10.1159/000546972 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Innate Immunity, online erschienen am 18.06.2025. Verfasst von Lijie Hao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lymphocytes, Intestinal Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: The incidence of intestinal diseases is increasing every year, placing a heavy burden on the world’s health and economy. The interaction of immune, microbial, and environmental factors leading to chronic inflammation and immune dysfunction has gradually become a focus of research on the pathogenesis of intestinal diseases. Among them, type 3 innate lymphoid cells (ILC3s) have attracted much attention due to their unique features. Summary: This paper has been carefully reviewed to provide a comprehensive overview of the roles of ILC3s in maintaining the homeostasis of intestinal flora. Initially, the effects of various intestinal microbiota, including bacteria, fungi, viruses, and pathogenic bacteria, on the function of ILC3s were introduced in detail. Subsequently, it summarizes how ILC3 imbalance disrupts the intestinal barrier and leads to digestive diseases, including infectious diseases, colorectal cancer, inflammatory bowel disease, and irritable bowel syndrome. Key Messages: By reviewing the role of ILC3s in maintaining the homeostasis of the intestinal flora and the current research status of ILC3s imbalance disrupting the intestinal barrier and leading to digestive tract diseases, this review provides potential immunotherapy targets for the future and offers a basis for the construction of future animal models and the conduct of clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Hao, L., Ge, Y., Chen, Z., Yuan, D., Zhang, X., Zhai, H., & Liu, Z. (2025). Interaction between Group 3 Innate Lymphoid Cells, Microbiota, and Intestinal Diseases: Mechanisms and Therapeutic Potential. Journal of Innate Immunity, 17(1), 341-353. https://doi.org/10.1159/000546972
Vancouver
Hao L, Ge Y, Chen Z, Yuan D, Zhang X, Zhai H, et al. Interaction between Group 3 Innate Lymphoid Cells, Microbiota, and Intestinal Diseases: Mechanisms and Therapeutic Potential. Journal of Innate Immunity. 2025;17(1):341-353. doi:10.1159/000546972
BibTeX
@article{Hao2025,
author = {Hao, Lijie and Ge, Yi and Chen, Zhuo and Yuan, Duo and Zhang, Xiaoyan and Zhai, Huihong and Liu, Ziyu},
title = {Interaction between Group 3 Innate Lymphoid Cells, Microbiota, and Intestinal Diseases: Mechanisms and Therapeutic Potential},
journal = {Journal of Innate Immunity},
year = {2025},
volume = {17},
number = {1},
pages = {341--353},
doi = {10.1159/000546972}
}
EUVIMED